SARS-CoV-2 IgG (RBD)
ELISA Market
SARS-CoV-2 IgG (RBD) ELISA Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
SARS-CoV-2 IgG (RBD) ELISA Market Size and Growth
The SARS-CoV-2 IgG (RBD) ELISA market is experiencing substantial growth, driven by increasing demand for COVID-19 diagnostics and immunity assessments. The market size is projected to reach approximately $XX million by 2025, reflecting robust investments in research and development, alongside advancements in testing technologies and rising awareness of public health initiatives.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ R&D Systems
◍ Thermo Fisher Scientific
◍ Ortho Clinical Diagnostics
◍ BD Biosciences
◍ ZEUS Scientific
◍ Bio-Rad Laboratories
◍ ALPCO
◍ Enzo Life Sciences
◍ BioMérieux
◍ LOEWE Biochemica
◍ Shenzhen YHLO Biotech
◍ LG
The SARS-CoV-2 IgG (RBD) ELISA market features key players like R&D Systems, Thermo Fisher Scientific, and BD Biosciences, which innovate testing solutions, expand product portfolios, and enhance diagnostics. Sales revenues for some companies include: Thermo Fisher: ~$30 billion, Bio-Rad: ~$2.5 billion, Ortho Clinical: ~$1.5 billion.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Disease control and prevention system
By Product
ELISA Sets
ELISA Kits
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
